A distributor of pharmaceutical and medical products, Cardinal climbed one spot on this year’s 500 thanks to a 7% jump in sales. While business was brisk, weak pricing of generic drugs and the loss of a contract with Safeway led to a 10% loss in profits in 2017. Like its competitors, Cardinal has come under fire–and faces a bevy of lawsuits–for its alleged role in the nation’s opioid epidemic.
Looking for leads, investment insights, or competitive intelligence?
News about Cardinal Health
Attorney General Jeff Sessions announced a "statement of intent" to prop up suits against opioid makers and distributors.
Sparking a selloff in the shares of a host of health care-related companies.
Amazon is reportedly talking to drug firms.
The special Sino Saturday edition of CEO Daily.
Corporate governance matters, too.